Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00418509 | Study of Mometasone Furoate/Formoterol Fumarate Inhalation Combination in Healthy Volunteers | PHASE1 | COMPLETED | 24 | — | — | Nov 1, 2006 | - | Jun 22, 2007 | 1 | United Kingdom |
| Name | Type | Description |
|---|---|---|
| Mometasone furoate | DRUG | - |
| Formoterol fumarate | DRUG | - |
Inclusion Criteria: * Healthy, male or female subjects age 18 to 65 years of age (included) * In good health as confirmed by past medical history * Female subjects must be either surgically sterilized at least 6 months prior to study participation or post-menopausal (no regular menstrual bleeding f...